New hope for advanced anal cancer: major trial tests Immune-Boosting drug
NCT ID NCT04472429
Summary
This large, completed Phase 3 trial tested whether adding a new immunotherapy drug (retifanlimab) to standard chemotherapy could better control advanced anal cancer that cannot be removed by surgery. The study involved 308 adults worldwide who had not received prior chemotherapy for their advanced disease. Participants were randomly assigned to receive either the real immunotherapy drug or a placebo (dummy drug) along with their chemotherapy, and researchers measured how long the cancer was kept from growing and how long patients lived.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke'S Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Aichi Cancer Center Hospital
Nagoya, 464-8681, Japan
-
Asklepios Klinik Altona
Hamburg, 22763, Germany
-
Azienda Ospedaliera Universitaria University Degli Studi Della Campania Luigi Vanvitelli
Napoli, 80131, Italy
-
Azienda Ospedaliero Universitaria Ospedali Riuniti
Torrette, 60020, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, 56126, Italy
-
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, 20162, Italy
-
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, 20162, Italy
-
Baylor Scott and White Research Institute
Dallas, Texas, 75246, United States
-
Blue Ridge Cancer Care
Roanoke, Virginia, 24014, United States
-
Castle Hill Hospital
Hull, HU16 5JQ, United Kingdom
-
Center Hospital of the National Center For Global Health and Medicine
Shinjuku-ku, 162-8655, Japan
-
Centre Antoine Laccassagne
Nice, 06200, France
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33075, France
-
Centre Leon Berard
Lyon, 69008, France
-
Centre de Lutte Contre Le Cancer - Institut de Cancerologie de L'Ouest - Rene Gauducheau
Saint-Herblain, 44800, France
-
Chu Besancon Hospital Jean Minjoz
Besançon, 25030, France
-
Chu Hopital de La Timone
Marseille, 13385, France
-
Chu Toulouse Hopital Rangueil
Toulouse, 31059, France
-
Chu de Rennes - Hospital Pontchaillou
Rennes, 35033, France
-
Churchill Hospital
Oxford, OX3 7LE, United Kingdom
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano
Milan, 20133, Italy
-
Complejo Hospitalario Universitario A Coruna
A Coruña, 15006, Spain
-
European Institute of Oncology
Milan, 20141, Italy
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
-
Fondazione Irccs Ca Granda Ospedale Maggiore
Milan, 20122, Italy
-
Haukeland University Hospital
Bergen, 05021, Norway
-
Herlev Og Gentofte Hospital
Herlev, 02730, Denmark
-
Hopital Charles Nicolle Chu Rouen Hospital de Bois-Guillaume
Rouen, 76031, France
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital General Universitario Vall D Hebron
Barcelona, 08035, Spain
-
Hospital Universitaire Pitie-Salpetriere
Paris, 75651, France
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Hospital Universitario Virgen Del Rocio
Seville, 41013, Spain
-
Hospital Universitario de La Paz
Madrid, 28046, Spain
-
Hospital de La Miletrie
Poitiers, 86021, France
-
I.R.C.C.S. Casa Sollievo Della Sofferenza
San Giovanni Rotondo, 71013, Italy
-
Institut Du Cancer de Montpellier
Montpellier, 34298, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut de Cancerologie de L Ouest - Site Paul Papin
Angers, 49055, France
-
Institut de Cancerologie de Strasbourg
Strasbourg, 67200, France
-
Iov - Istituto Oncologico Veneto Irccs
Padua, 35128, Italy
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
Leeds Teaching Hospital
Leeds, LS 9 7TF, United Kingdom
-
Maryland Oncology Hematology, P.A.
Columbia, Maryland, 21044, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Monash Medical Centre Clayton
Clayton, Victoria, 03168, Australia
-
National Cancer Center Hospital
Chūōku, 104-0045, Japan
-
Ochsner Clinic
New Orleans, Louisiana, 70121, United States
-
Osaka International Cancer Institute
Osaka, 541-8567, Japan
-
Oslo Universitetssykehus
Oslo, 00450, Norway
-
Ospedale Degli Infermi
Rimini, 47923, Italy
-
Panoncology Trials Pan American Center For Oncology Trials, Llc
San Juan, 00935, Puerto Rico
-
Princess Alexandra Hospital Australia
Woolloongabba, Queensland, 04102, Australia
-
Renovatio Clinical Consultants Llc
The Woodlands, Texas, 77380, United States
-
Rocky Mountain Cancer Center
Denver, Colorado, 80218, United States
-
Royal Cornwall Hospital Truro Sunrise Centre
Truro, TR1 3LQ, United Kingdom
-
Royal Free London Nhs Foundation Trust
London, NW3 2QG, United Kingdom
-
Royal Preston Hospital
Preston, PR2 9HT, United Kingdom
-
Royal Surrey County Hospital
Guildford, GU2 7XX, United Kingdom
-
Royal Sussex County Hospital
Brighton, BN2 5BE, United Kingdom
-
Sahlgrenska University Hospital
Gothenburg, 413 45, Sweden
-
Saitama Medical University International Medical Center
Hidaka-shi, 350-1298, Japan
-
Sansum Clinic
Santa Barbara, California, 93105, United States
-
Skaenes Universitetssjukhus Lund
Lund, 22185, Sweden
-
Son Espases University Hospital
Palma de Mallorca, 07120, Spain
-
Stockholm South General Hospital Sodersjukhuset
Stockholm, 118 83, Sweden
-
Texas Oncology
Austin, Texas, 78745, United States
-
Texas Oncology-Wichita Falls Texoma Cancer Center
Wichita Falls, Texas, 76310, United States
-
The Christie Nhs Foundation Trust Uk
Manchester, M20 4BV, United Kingdom
-
The Royal Marsden Nhs Foundation Trust - Chelsea
London, SW3 6JJ, United Kingdom
-
The Royal Marsden Nhs Foundation Trust - Sutton
Sutton, SM2 5PT, United Kingdom
-
The University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
-
Tohoku University Hospital
Sendai, 980-8574, Japan
-
UC Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
Ulb Hospital Erasme
Brussels, 01070, Belgium
-
Universitatsklinikum Bonn Aoer
Bonn, 53127, Germany
-
University Clinic Carl Gustav Carus Technical University Dresden
Dresden, 01307, Germany
-
University Di Cagliari-Presidio Policlinico Monserrato
Monserrato, 09042, Italy
-
Vejle Hospital
Vejle, 07100, Denmark
-
Virginia Cancer Specialists, Pc
Arlington, Virginia, 22205, United States
-
Zna Middelheim
Antwerp, 02020, Belgium
Conditions
Explore the condition pages connected to this study.